반응형

CE 39

[유럽, CE] Possible second call for EU reference laboratories for high-risk in vitro diagnostic medical devices

Background - EURL designation 2023 In July 2022, the European Commission launched a call for the designation of EU reference laboratories in 8 categories of class D devices. Applicant laboratories had six months to prepare and submit applications to their Member State. The Commission reviewed the applications based on the following elements specified in the call: the applicant laboratories must ..

유럽 MDR, IVDR 2024.03.11

[CE] The European Proposal to Delay Compliance for Legacy IVDs and EUDAMED Rollout

The European Commission (EC) has made a proposal (COM(2024)43/ 5712/24) to delay compliance of legacy IVD devices and for EUDAMED to be rolled out by modules completed. The proposal would extend the time for manufacturers of legacy IVDs to become compliant with the IVDR. Also, analogous to Regulation (EU) 2023/607, requires an application with a notified body designated for the IVDR and an agree..

유럽 MDR, IVDR 2024.02.26

[CE] MDCG 2024-1 - Device Specific Vigilance Guidance (DSVG) Template - January 2024

The aim of this Device Specific Vigilance Guidance (DSVG) is to harmonise vigilance reporting and provide guidance for manufacturers of Specific Devices. It provides further clarification for vigilance reporting of Specific Devices to the relevant Competent Authority and should be read in conjunction with the requirements of Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2..

유럽 MDR, IVDR 2024.02.20

[EU, CE] EU Update: Deadline nears for medical device Regulation 2023/607

The first deadline for Regulation 2023/607 is rapidly approaching. Manufacturers of legacy medical devices sold in the EU market will receive a regulatory reprieve when Regulation 2023/607 System and Procedure Packs goes into effect May 26, as long as certain conditions are met. About Regulation 2023/607 We briefly share again the requirements for Regulation 2023/607 amending the European Medica..

유럽 MDR, IVDR 2024.02.07

[CE] Commission proposes to extend transition periods for certain IVDs, gradual roll-out of Eudamed and an information obligation in case of interruption of supply

In 2017, the EU introduced new rules for medical devices and in vitro diagnostics to ensure a better protection of public health and patient safety. Despite considerable progress in transitioning to these rules and the additional time given to the sector to implement them, the transition remains slow. In 2023, the Commission took measures to ensure the availability of medical devices. Today, we ..

유럽 MDR, IVDR 2024.02.01

[CE, PRRC] ‘24년 1차 의료기기 유럽인증 규제준수 책임자(PRRC) 교육신청 안내

한국의료기기협동조합에서 유럽인증 규제준수 책임자 (PRRC) 교육이 예정되어 있다. 자세한 내용은 아래 링크를 참고해 주시기 바랍니다. ▶ 교육일시: 2024년 03월 04일(월) ~ 05일(화) 09:30 ~ 17:30 ▶ 교육장소: 삼경교육센터 6층 (서울 용산구 한강대로 391 센트럴플라자) ▶ 교육인원: 40명 ▶ 교육비용: 회원사 270,000원 / 비회원사 330,000원 [교육모집]‘24년 1차 의료기기 유럽인증 규제준수 책임자(PRRC) 교육신청 안내 – 한국의료기기협동조합 (medinet.or.kr) [교육모집]‘24년 1차 의료기기 유럽인증 규제준수 책임자(PRRC) 교육신청 안내 medinet.or.kr

[EU] EU Update: Overview of European Language Requirements for Medical Devices

To help medical device and IVD manufacturers understand the national language requirements under the Medical Devices Regulation (2017/745, MDR) and In Vitro Diagnostic Devices Regulation (2017/746, IVDR), the European Commission recently published two tables on its website (January 17) with links for the relevant legal provisions for each member state. The MDR and IVDR contain regulatory require..

유럽 MDR, IVDR 2024.01.24
반응형